The US Food and Drug Administration (FDA) has renewed its funding for the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) under a new five-year, $50 million cooperative agreement.
M-CERSI is a partnership between the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) and is led by James Polli, PhD, the Shangraw/Noxell Endowed Chair in Industrial Pharmacy and Pharmaceutics in the Department of Pharmaceutical Sciences (PSC) at UMSOP, and William Bentley, PhD, the Robert E. Fischell Distinguished Professor and Director of the Robert E. Fischell Institute for Biomedical Devices at UMCP. The FDA’s Office of Regulatory Science and Innovation collaborates with M-CERSI on its activities.
Read the full story on the School of Pharmacy's News Center.